Japan’s pharma industry is the 2nd largest in Asia and the third-largest worldwide following the US and China. Gathering over 550 exhibitors and 20,000 pharma professionals from around the world, CPhI Japan is the ideal platform to tap into this attractive market and source the latest technologies and innovative products!
The Japanese pharma industry is the third largest worldwide following the US and China and is estimated to reach a value of $109 billion by 2026.
R&D in Japan is at the forefront of the global pharmaceutical industry – a result of both the attractiveness of the nation’s medicine market and the strength of local research institutions.
A speedier and more efficient drug approval process has led to international investors re-establishing Japanese R&D centres and upping investments in the country.
There is a lot of focus on the generics sector in Japan with the nation's government going as far as to identify the growth of its generics market as "imperative to Japan's long-term economic health".
With the Japanese government looking to grow the generic drugs sector the demand for APIs is set to rise and the country will continue to search further for supplier options.
The global Standardisation means easier entry for foreign companies & sees Japanese companies cooperating and building strong relationships with international partners.
Manage your Registration
If you have already pre-registered for the event, you can manage your registration on Visitor My Page. Sign in on the platform using the login details you have received by email. On this portal you will be able to:
• Request an invitation letter for your visa application
• Request to resend the confirmation of your registration for the event
• Check the seminar programmes you have enrolled for and request a new confirmation email
Having trouble signing into your account? Forgot your login details? Please email our customer service team.